HomeNewsBusinessCOVID-19 a defining moment; these are the times to question everything, says Harsh Mariwala

COVID-19 a defining moment; these are the times to question everything, says Harsh Mariwala

The Marico chairman talks on lessons and life during COVID-19, and shares how he makes the most of work from home.

April 08, 2020 / 14:18 IST
Story continues below Advertisement

Harsh Mariwala has been an entrepreneur for nearly 50 years, and has seen through many a boom and downturn to create a billion-dollar enterprise in Marico. But even the seasoned entrepreneur has been taken aback by the disruption created by COVID-19.

"I have never seen anything like this in my career," says Mariwala in an interaction with Moneycontrol. 

Story continues below Advertisement

At the same time, the Marico chairman believes, this could be a defining moment. "These are the times when you virtually start questioning everything. There are lessons for all human beings, the attention we give to health or environment, and issues like sustainability and even supply chain issues," said Mariwala.

India has now reported 5,000 people with the COVID-19 infection, and 149 have died. Globally, the virus has taken the lives of more than 82,000 people, and nearly 15 lakh people have been reportedly infected.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show